Celcuity (CELC) Change in Acquisitions & Divestments (2018 - 2025)
Celcuity's (CELC) quarterly Change in Acquisitions & Divestments came in at $103.5 million in Q4 2025, down 54.46% YoY from $227.2 million in Q4 2024, and up 220.25% on a QoQ basis from $32.3 million in Q3 2025.
Analysis
Celcuity (CELC) Change in Acquisitions & Divestments (2018 - 2025) Analysis & Trends
Celcuity (CELC) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $103.5 million in Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 54.46% year-over-year to $103.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $332.5 million (down 48.24% YoY) and the FY2025 annual result came in at $332.5 million, down 48.24% from the prior year.
- Change in Acquisitions & Divestments climbed to $103.5 million in Q4 2025, from $32.3 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $227.2 million in Q4 2024 to a low of $25.0 million in Q1 2023.
- A 3-year average of $107.0 million and a median of $111.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 400.24% — and 2025, when it plunged 79.12%.
- Tracing CELC's Change in Acquisitions & Divestments over 3 years: stood at $88.6 million in 2023, then soared by 156.56% to $227.2 million in 2024, then slumped by 54.46% to $103.5 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $103.5 million (Q4 2025), $32.3 million (Q3 2025), and $129.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Celcuity | 5.25 Bn | 5.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 103.46 Mn |
| Sep 30, 2025 | 32.31 Mn |
| Jun 30, 2025 | 129.93 Mn |
| Mar 31, 2025 | 66.81 Mn |
| Dec 31, 2024 | 227.21 Mn |
| Sep 30, 2024 | 154.75 Mn |
| Jun 30, 2024 | 135.33 Mn |
| Mar 31, 2024 | 125.06 Mn |
| Dec 31, 2023 | 88.56 Mn |
| Sep 30, 2023 | 77.18 Mn |
| Jun 30, 2023 | 118.87 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2019 | 4.17 Mn |
| Sep 30, 2019 | 3.00 Mn |
| Jun 30, 2019 | 1.50 Mn |
| Mar 31, 2019 | 245,000.00 |
| Dec 31, 2018 | 13.81 Mn |
| Sep 30, 2018 | 2.49 Mn |
| Jun 30, 2018 | 4.53 Mn |
| Mar 31, 2018 | 2.14 Mn |